First Report of Aeromonas veronii as an Emerging Bacterial Pathogen of Farmed Nile Tilapia (Oreochromis niloticus) in Brazil
Authors:
- Sandie Bispo dos SantosSSSandie Bispo dos Santos
- Miguel Fernandez AlarconMAMiguel Fernandez Alarcon
- Anelise Stella BallabenABAnelise Stella Ballaben
- Ricardo HarakavaRHRicardo Harakava
- Renata GalettiRGRenata Galetti
- Mateus Cardoso GuimarãesMGMateus Cardoso Guimarães
- Mariene Miyoko NatoriMNMariene Miyoko Natori
- Leonardo Susumu TakahashiLeonardo Susumu Takahashi
- Ricardo IldefonsoRIRicardo Ildefonso
- Marco Rozas-SerriMarco Rozas-Serri
Open Access
Abstract
Brazil is one of the world’s leading producers of Nile tilapia, Oreochromis niloticus. However, the industry faces a major challenge in terms of infectious diseases, as at least five new pathogens have been formally described in the last five years. Aeromonas species are Gram-negative anaerobic bacteria that are often described as fish pathogens causing Motile Aeromonas Septicemia (MAS). In late December 2022, an epidemic outbreak was reported in farmed Nile tilapia in the state of São Paulo, Brazil, characterized by clinical signs and gross pathology suggestive of MAS. The objective of this study was to isolate, identify, and characterize in vitro and in vivo the causative agent of this epidemic outbreak. The bacterial isolates were identified as Aeromonas veronii based on the homology of 16S rRNA (99.9%), gyrB (98.9%), and the rpoB gene (99.1%). A. veronii showed susceptibility only to florfenicol, while it was resistant to the other three antimicrobials tested, oxytetracycline, enrofloxacin, and amoxicillin. The lowest florfenicol concentration capable of inhibiting bacterial growth was ≤0.5 µg/mL. The phenotypic resistance of the A. veronii isolate observed for quinolones and tetracycline was genetically confirmed by the presence of the qnrS2 (colE plasmid) and tetA antibiotic-resistant genes, respectively. A. veronii isolate was highly pathogenic in juvenile Nile tilapia tested in vivo, showing a mortality rate ranging from 3 to 100% in the lowest (1.2 × 104) and highest (1.2 × 108) bacterial dose groups, respectively. To our knowledge, this study would constitute the first report of highly pathogenic and multidrug-resistant A. veronii associated with outbreaks and high mortality rates in tilapia farmed in commercial net cages in Brazil.Keywords
Funding Information
- Chilean Production Development Corporation (CORFO 20CVID-128114)
This publication has 52 references indexed in Scilit:
- Comparative Pathogenomics of Bacteria Causing Infectious Diseases in FishInternational Journal of Evolutionary Biology, 2012
- Detection and characterization of virulence genes and integrons in Aeromonas veronii isolated from catfishFood Microbiology, 2010
- The GenusAeromonas: Taxonomy, Pathogenicity, and InfectionClinical Microbiology Reviews, 2010
- Resistance Plasmid Families in EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2009
- New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilisAntimicrobial Agents and Chemotherapy, 2009
- qnrD , a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human OriginAntimicrobial Agents and Chemotherapy, 2009
- Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in SalmonellaJournal of Antimicrobial Chemotherapy, 2008
- Mentol e eugenol como substitutos da benzocaína na indução anestésica de juvenis de pacuActa Scientiarum. Animal Sciences, 2008
- European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testingClinical Microbiology and Infection, 2006
- Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamasesJournal of Antimicrobial Chemotherapy, 2005